For FGFR3 mutations no significant difference in overall survival was noted for HPV-associated HNSCC and there were insufficient patients with FGFR3 mutations in TCGA to evaluate for an association with CESC (Supplementary Fig. 7). Here, FGFR3 is linked to head and neck squamous cell carcinoma.